In addition, it was recently shown that in alveolar soft part sarcoma, the expression of the fusion transcription factor ASPSCR1::TFE3 is required for in vivo tumor development via angiogenesis, orchestrating higher-ordered angiogenesis via super-enhancers activity [22]. The gene discussed is ASPSCR1; the disease is soft tissue sarcoma.